85 related articles for article (PubMed ID: 3090175)
1. Enhanced expression of HLA antigens on gynecologic cancer cells by interferon-gamma.
Okamura K; Abe Y; Yamada K; Uehara S; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):945-8. PubMed ID: 3090175
[TBL] [Abstract][Full Text] [Related]
2. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar.
Anderson DJ; Berkowitz RS
J Immunol; 1985 Oct; 135(4):2498-501. PubMed ID: 3928751
[TBL] [Abstract][Full Text] [Related]
3. [Studies on HLA-class I and class II antigen expression in cultured choriocarcinoma cell lines].
Yamashita K; Nakamura T; Shimizu T; Ikeda H; Katagiri M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):17-22. PubMed ID: 3512743
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines.
Trowsdale J; Travers P; Bodmer WF; Patillo RA
J Exp Med; 1980 Aug; 152(2 Pt 2):11s-17s. PubMed ID: 6157763
[TBL] [Abstract][Full Text] [Related]
5. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of HLA-DR antigen expression on choriocarcinoma].
Yamashita K; Nakamura T; Shimizu T; Ikeda H; Katagiri M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1901-6. PubMed ID: 6389728
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
8. Normal trophoblasts resist induction of class I HLA.
Hunt JS; Andrews GK; Wood GW
J Immunol; 1987 Apr; 138(8):2481-7. PubMed ID: 3104468
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line.
Ellis SA; Sargent IL; Redman CW; McMichael AJ
Immunology; 1986 Dec; 59(4):595-601. PubMed ID: 3804380
[TBL] [Abstract][Full Text] [Related]
10. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
Ball ED; Sorenson GD; Pettengill OS
Cancer Res; 1986 May; 46(5):2335-9. PubMed ID: 3008987
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
12. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
[TBL] [Abstract][Full Text] [Related]
13. [HLA antigens in choriocarcinoma].
Sasagawa M; Suzuki T; Kajino T; Ohno M; Kanazawa K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):81-4. PubMed ID: 6366090
[TBL] [Abstract][Full Text] [Related]
14. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
Yoshino I; Peoples GE; Goedegebuure PS; Maziarz R; Eberlein TJ
J Immunol; 1994 Mar; 152(5):2393-400. PubMed ID: 8133050
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA class I and class II antigens in human choriocarcinoma cell lines.
Yamashita K; Nakamura T; Shimizu T; Katagiri M; Ikeda H
Int J Gynaecol Obstet; 1986 Aug; 24(4):301-7. PubMed ID: 2878840
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
17. The role of MHC class I expression in developmental tumours.
Stern PL; Rinke de Wit TF
Semin Cancer Biol; 1991 Feb; 2(1):11-6. PubMed ID: 1912513
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
19. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
